Labshake search
Citations for MedChemExpress :
1 - 5 of 5 citations for JAK1 Rabbit Recombinant mAb since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2020Quote: The selective Janus kinase 1 and 2 (JAK1/2) inhibitors baricitinib (LY3009104, INCB028050) and ruxolitinib (INCB18424) were obtained from MedChemExpress (Monmouth Junction, NJ). For subcutaneous administration ...
-
bioRxiv - Immunology 2023Quote: ... the cells were pre-treated for 2h with 4 µM of the JAK1/2 inhibitor Baricitinib (Selleckchem, Planegg, Germany)6 or 0.3 µM of the TYK2 inhibitor BMS-986165 (MedChemExpress, Monmouth Junction, NJ, USA)39 or their respective vehicle before treatment with IFNα.
-
bioRxiv - Immunology 2024Quote: ... the LLC cell line was treated with recombinant CCL8 (MedChemExpress, Cat#: HY-P7771) at 0 ...
-
bioRxiv - Biochemistry 2022Quote: ... Two days after the transfection recombinant cells were selected by adding 2 μg/mL of doxycycline (dox) and 10 nM of AP1903 (MedChemExpress). Cells were selected for 48 hours after which they were allowed to grow for another 48 hours to ensure the expression of the transgenes reached steady state levels before performing flow cytometry profiling.
-
bioRxiv - Cell Biology 2023Quote: ... An in vitro OA model was induced by treating rat primary chondrocytes with recombinant rat Interleukin-1β (IL-1β) (10 ng/mL) (MedChemExpress, Shanghai, China) for 24 h ...